ABSTRACT
Cervical cancer imaging is very important for correct treatment planning and prognosis determination. In the latest version of the International Federation of Gynecology and Obstetrics-2018; staging, cross-sectional imaging and pathological findings were included in the system. Magnetic resonance imaging in determining tumor size and parametrial involvement, and cross-sectional imaging, especially 18F-fluorodeoxyglucose positron emission tomography/computed tomography in determining lymph node involvement and distant metastases have an increased role.
